Catalysts for Janssen Therapeutics
248 tracked
Jan 15, 2019
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 15, 2019
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Dec 27, 2018
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Dec 27, 2018
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Nov 7, 2018
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jul 30, 2018
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jun 19, 2018
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jun 19, 2018
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Dec 5, 2017
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Oct 27, 2017
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jun 28, 2017
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
May 12, 2017
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
May 12, 2017
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Feb 23, 2017
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Feb 10, 2017
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 4, 2017
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Nov 30, 2016
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Aug 25, 2016
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Aug 25, 2016
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Aug 17, 2016
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
May 18, 2016
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Oct 26, 2015
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
May 11, 2015
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
May 5, 2015
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Apr 17, 2015
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Feb 16, 2015
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 15, 2015
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Dec 19, 2014
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Dec 18, 2014
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Dec 18, 2014
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→